Vaccine Development Centre

The Vaccine Development Centre (VDC) is VIDO’s new vaccine manufacturing facility. The VDC supports human and animal vaccine development from discovery to commercialization.

In the VDC, we can produce vaccines for human clinical trials and veterinary vaccines for commercial use. All vaccines are produced using Good Manufacturing Practice (GMP) standards, which are used by regulatory agencies to ensure medicines are produced safely.

Centre Highlights:

• Containment level 3 capable for Risk Group 3 pathogens

• Good Manufacturing Practice (GMP) compliant
• Up to 1,000L bioreactors and 500m² fixed-bed bioreactor
• Capacity to produce all major vaccine platforms, GMP virus and phage, and other biologics
• Expertise to take new products from the laboratory-scale to full-scale manufacturing

For more information on our services please download our brochure.